You have no items in your shopping cart.
IL-22 Recombinant Protein
Description
Research Area
Images & Validation
−
Key Properties
−| Source | E. coli |
|---|---|
| Biological Activity | Biological activity was determined by its ability to induce STAT3 activation in COLO 205 cells. The expected ED50 for this effect is 150-400 pg/ml. |
| Target | Il22 |
| Protein Sequence | MLPVNTRCKL EVSNFQQPYI VNRTFMLAKE ASLADNNTDV RLIGEKLFRG VSAKDQCYLM KQVLNFTLED VLLPQSDRFQ PYMQEVVPFL TKLSNQLSSC HISGDDQNIQ KNVRRLKETV KKLGESGEIK AIGELDLLFM SLRNACV |
| Purity | Greater than 98% by SDS-PAGE gel and HPLC analyses.Endotoxin level is less than 0.1 ng per μg (1EU/μg). |
Storage & Handling
−| Storage | The lyophilized IL-22 recombinant protein is stable for at least 2 years from date of receipt at -20°C. Reconstituted IL-22 is stable for at least 3 months when stored in working aliquots with a carrier protein at -20°C. As with any protein, exposing IL-22 recombinant protein to repeated freeze / thaw cycles is not recommended. When working with proteins care should be taken to keep recombinant protein at a cool and stable temperature. |
|---|---|
| Form/Appearance | Lyophilized |
| Expiration Date | 6 months from date of receipt. |
| Disclaimer | For research use only |
Alternative Names
−Similar Products
−Recombinant Human IL-22 Protein [orb2994578]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 16.9 KDa. Observed: 14 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mgRecombinant Human IL-22 Protein [orb2994085]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 17.7 KDa. Observed: 25-35 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mgRecombinant Human IL-22 Protein [orb2994086]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 17.9 KDa. Observed: 25-35 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mgRecombinant Mouse IL-22 Protein [orb2994339]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 43.8 KDa. Observed: 50-65 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mgRecombinant Human IL-22 Protein [orb2994340]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 43.4 KDa. Observed: 50-75 KDa, reducing conditions
50 μg, 500 μg, 1 mg, 10 μg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.
Quick Database Links
UniProt Details
−NCBI Reference Sequences
−| Protein | NP_058667.1 |
|---|
Documents Download
Request a Document
Protocol Information
IL-22 Recombinant Protein (orb1230687)
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review